The general conclusions of those scientific studies are that ximelagatran is just not inferior to standard therapy for the acute therapy of DVT and it is outstanding to placebo for extended secondary prevention of recurrent DVT and/or PE. Identify your collection: Identify should be a lot less than a hundred https://jamesw728zyg5.wikiconversation.com/user